This catalogue is deliberately short: eight research peptides and bacteriostatic water, rather than a list of sixty compounds most of which sit out of stock. Every peptide in it has been analysed by an independent laboratory, and the report is published in full on the certificates page — laboratory name, measured content, purity, analysis date and, where the report carries one, the verification code.
Two laboratories do the work. Janoshik covers most of the range; Kovera Labs issued the HPLC and LC-MS reports for BPC-157 and GLOW, both with chromatograms. Five of the eight reports carry a code that can be entered at the issuing laboratory’s own site, so the result can be confirmed without taking our word for it. The three that arrived with the code obscured are marked as such rather than left looking verifiable.
The retatrutide reports were run as a blind GLP-1 panel — the laboratory screened for semaglutide, tirzepatide and retatrutide without being told which to expect. That is a harder test to pass than an assay aimed at a single expected compound.
Full terms are on the shipping policy page.
All products listed on this page are supplied for scientific research and laboratory use only. They are not therapeutic goods, are not for human or veterinary consumption, and nothing on this page is a claim that any compound treats, prevents or diagnoses any condition.
Need more information about Peps Aussie? Get in contact with us via the email below and Peps Aussie will assist you promptly.
Include your name and a relevant subject line.
Every batch we publish a third-party certificate of analysis. Get told when a new one lands, and when a sold-out peptide is back.
